The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
doi: https://doi.org/10.1101/2020.05.13.20101253
John P.A. Ioannidis
Departments of Medicine, of Epidemiology and Population Health, of Biomedical Data Science, and of Statistics and Meta-Research Innovation Center at Stanford (METRICS), Stanford University, Stanford, CA, USA
![Loading Loading](https://www.medrxiv.org/sites/all/modules/contrib/panels_ajax_tab/images/loading.gif)
Data Availability
All data are included in the manuscript
Posted May 19, 2020.
The infection fatality rate of COVID-19 inferred from seroprevalence data
John P.A. Ioannidis
medRxiv 2020.05.13.20101253; doi: https://doi.org/10.1101/2020.05.13.20101253
Subject Area
Subject Areas
- Addiction Medicine (330)
- Allergy and Immunology (652)
- Anesthesia (174)
- Cardiovascular Medicine (2522)
- Dermatology (211)
- Emergency Medicine (386)
- Epidemiology (12002)
- Forensic Medicine (10)
- Gastroenterology (721)
- Genetic and Genomic Medicine (3915)
- Geriatric Medicine (367)
- Health Economics (655)
- Health Informatics (2531)
- Health Policy (975)
- Hematology (352)
- HIV/AIDS (814)
- Medical Education (390)
- Medical Ethics (106)
- Nephrology (420)
- Neurology (3677)
- Nursing (205)
- Nutrition (548)
- Oncology (1911)
- Ophthalmology (557)
- Orthopedics (231)
- Otolaryngology (299)
- Pain Medicine (244)
- Palliative Medicine (71)
- Pathology (466)
- Pediatrics (1077)
- Primary Care Research (436)
- Public and Global Health (6354)
- Radiology and Imaging (1342)
- Respiratory Medicine (847)
- Rheumatology (389)
- Sports Medicine (335)
- Surgery (426)
- Toxicology (51)
- Transplantation (180)
- Urology (156)